Introduction
We have two main aims in writing this paper: the roles in the development of mouse kidneys, which are organs that will undergo organotypic development in simple culture conditions and that are therefore highly accessible to experimentation. Depleting kidneys of GAGs, either biochemically or genetically, blocks the development of the urinary collecting-duct system, probably because critical signalling molecules require GAGs to form stable associations with their receptors. T h e insensitivity of GAG-deprived organ rudiments to physiological concentrations of growth factors can Key words: branching, chlorate, chondroitin, heparan, kidney. Abbreviations used: GAG, glycosaminoglycan; FGF, fibroblast growth factor: FGFR fibroblast growth factor receptor; HGF, hepatocyte growth factor; GDNF. glial cell line-derived growth factor; MAP, mitogen-activated protein.
[To whom correspondence should be addressed (e-mail Jamie. Davies@ed.ac.uk). first is to review the evidence that glycosaminoglycans (GAGs) influence the development of mammalian organs, particularly the kidney; the second is to explain how experimental manipulation of GAGs can be used to identify signalling molecules that regulate organ development.
GAGs are linear polysaccharides produced by polymerization of basic disaccharide units, each of which consists of an amino sugar (N-acetylglucosamine or N-acetyl galactosamine) and a uronic acid (glucuronic acid or iduronic acid). T h e type of disaccharide unit varies between GAGs (for example, heparan has N-acetyl-glucosaminega~actosamine-g~ucuronic acid), and in most GAG types (hyaluronates are an exception), the saccharides are sulphated in various positions (see [I] for a review). Most GAGs are borne as long side glucuronic acid, while chondroitin has N-acetyl-
chains on protein cores to form proteoglycans, which are located either at the cell membrane (syndecans, glypicans etc.) or in the extracellular matrix (aggrecan, versican etc.) . GAGS in general interact with many GAG-binding proteins, and can therefore participate in many aspects of developmental cell biology including matrix organization, cell adhesion, directed cell migration, proliferation and apoptosis (for recent reviews, see
[2-61).
During the development of mammalian organs, proteoglycans show patterns of expression that are tightly controlled in space and time [7-131. Changes in proteoglycan expression frequently correlate with developmental events such as cell differentiation and mesenchymal condensation, suggesting that the molecules play a role in their regulation. We and others have begun to test this hypothesis using as our model system an organ that is unusually accessible to experimental intervention, the developing kidney.
An overview of kidney development
Several sets of kidneys form in the foetus; this review is concerned only with the permanent (metanephric) kidneys, which are the only kidneys that are not destroyed before birth. Metanephric kidneys arise from the meeting of two foetal tissues, the metanephrogenic mesenchyme and the ureteric bud (Fig. la) . T h e metanephrogenic mesenchyme is a specialized area of loosely packed mesenchymal cells at the caudal (hind-most) end of the intermediate mesoderm ; the ureteric bud is an epithelial tubule that emerges from the nephric duct and grows towards the mesenchyme. When the ureteric bud reaches and invades the mesenchyme, it branches dichotomously and repeatedly to produce the tree-like urinary collecting-duct system that will drain urine from the mature organ. As the ureteric bud branches, mesenchymal cells ' condense ' (cluster together) around its tips, and clumps of condensed cells form very tight aggregates that differentiate into epithelial cysts. These cysts then extend into tightly curved tubules, and undergo a series of morphological rearrangements to form excretory nephrons. As they mature, these nephrons develop specialized segments such as glomeruli, proximal convoluted tubules and the loop of HenlC. At an early stage of nephron morphogenesis, the distal ends of the nephrons fuse to nearby collecting ducts to form a continuous passage for urine. Mouse kidney rudiments will undergo substantial development in culture; if a rudiment consisting of metanephrogenic mesenchyme and an unbranched ureteric bud is removed from a day 10.5 mouse embryo and cultured on a polycarbonate membrane, its ureteric bud will branch organotypically and nephrons will form, differentiate and mature (Fig. lb) . Their robustness in culture makes developing kidneys unusually accessible to experimenters. Nearly half a century ago, Grobstein [ 141 used microdissection and culture of tissues to demonstrate that the ureteric bud and the mesenchyme are interdependent, neither tissue being able to develop without the other. This observation initiated an ongoing search for molecules that mediate interactions between the tissues. Cultured kidneys are highly accessible to antibodies, lectins, oligonucleotides and drugs, making the kidney a popular model system for exploring the mechanisms of epithelial differentiation and morphogenesis.
GAGs are important to renal development
Developing kidneys express heparan sulphate and chondroitin sulphates in the basement membranes of their epithelia and in the mesenchymal matrix [ 151. These GAG chains are carried on a variety of proteoglycan cores, each of which has a characteristic expression pattern (Table 1) .
The necessity for GAGs in kidney development can be demonstrated by treating kidney rudiments growing in culture with agents that destroy existing GAGs (e.g. heparinase I I I, chondroitinase ABC) or prevent GAG synthesis. One much-used agent that prevents GAG synthesis is sodium chlorate, which competes with sulphate for sulphotransferase enzymes and therefore blocks the sulphation of new GAG chains [16, 17] .
Kidney rudiments grown in 30 mM sodium chlorate show a complete failure of ureteric bud development, the bud remaining as a short, unbranched epithelial tube (Figs. 2a and 2b) , while lower concentrations of chlorate cause reduced bud branching and elongation. Quantitative study of ureteric bud morphogenesis in different concentrations of sodium chlorate (achieved by counting the numbers of bud tips formed in 72 h) reveals a remarkably close correlation with the amount of sulphated GAG synthesized [16] . Treatment of cultured kidney rudiments with T h e induction and development of nephrons still takes place even in 30 m M sodium chlorate; fewer nephrons form, but the number of nephrons per unit length of ureteric bud is similar to that in controls [16] . At first sight, this implies that nephrogenesis does not require GAGs, and that fewer form simply because there is less inducing tissue. It remains possible, however, that just the early stages of nephrogenesis do require GAGs, because the first nephrons that begin to form will do so before chlorate has managed to reduce the concentration of GAGs below critical levels.
A requirement for GAGs in vivo has been demonstrated by a heparan-sulphate-2-0-sulphotransferase-knockout mouse, which fails to develop kidneys [18] . In these mice, the ureteric bud forms normally and invades the mesenchyme, but the mesenchyme fails to condense around it and the bud fails to branch, although it does elongate somewhat. Nephrogenesis fails completely in these animals ; the apparent contradiction between this observation and reduced (not absent) nephrogenesis in GAG-depeleted cultures of wild-type kidneys may again be explained by a model in which nephrons require heparan 2-0-sulphatecontaining GAGs, but in amounts so low that enough remain even in chlorate/enzyme-treated wild-type kidneys. An alternative possibility is suggested by the fact that, in the knockout mouse, although heparan chains show no 0-sulphation in the 2 position, they have a great deal more in the 6 position so that they are more sulphated overall than in a wild-type animal [18a] . If this hyper-6-sulphated heparan were to be an active inhibitor of nephron development, there would be no contradiction between the knockout and the culture data.
GAGs have many biological functions that could be relevant to the developing kidney, but one of the most interesting is their ability to present growth factors to their high-affinity receptors. Many growth factors show moderately strong binding to heparan sulphate, a fact that is frequently used in their isolation by heparin affinity chromatography. In 1991 Rapraeger et al. and Yayon et al. [17, 19] showed that signalling by fibroblast growth factor (FGF) to its high-affinity receptor (FGFR) required cellular GAGs. Subsequently, detailed biochemical studies have shown that the F G F / F G F R complex binds different types of heparan sulphate chain with different affinities, showing a specificity that would, in principle, allow changes in GAG expression during development to modulate cellular responses to FGFs [20] . Genetic evidence has also shown that FGF signalling also requires GAGs; mutations of genes involved in sulphate activation, sulphate transport and GAG synthesis have phenotypes similar to those of FGF-related gene mutations [21-231. Both FGFs and FGFRs can bind to heparan sulphates, and thus stabilize their mutual interaction (see [24] for a review). Hepatocyte growth factor (HGF) also requires GAGs for signalling via its high-affinity receptor, c-Met [25] . Support for the idea that GAGs may be required for growth factor signalling in the kidney comes from the observations that depriving kidneys of GAGs reduces cell proliferation (as assessed by bromodeoxyuridine incorporation) in the ureteric bud, and that it also reduces expression of signalling molecules such as Wnt-1 1 [ 16,261. At the time that GAGs were first shown to be important to ureteric bud development, it was not possible to test directly whether they played a role in presenting morphoregulatory growth factors, because no such growth factors had been discovered in the kidney. T h e hypothesis that GAGs are required for presenting such factors did, however, suggest a means for their identification.
Depletion of GAGs as an investigative tool to identify inductive growth factors
Detailed work on the role of heparan sulphates in FGF signalling has shown that, while treatment of cells with chlorate makes them insensitive to physiological levels of growth factor, a response may still be elicited by supraphysiological concentrations, e.g. 30 x [27] . Conceivably, therefore, providing chlorate-treated kidney rudiments with supraphysiological concentrations of the appropriate growth factor would be able to rescue normal development. This is the basis of a screening method that we have so far used to assist identification of four morphoregulatory signalling molecules. Candidate growth factors are identified by reference to their known expression patterns and the expression patterns of their receptors, then high concentrations of purified growth factor are tested for their ability to rescue aspects of normal morphogenesis in chlorate-treated kidneys.
Many molecules that have been tested this way have no ability to rescue, but HGF, glial cell
I69
0 2001 Biochemical Society line-derived growth factor (GDNF), neurturin and persephin all have. H G F is normally produced in the mesenchyme and its c-Met receptor tyrosine kinase is expressed by the ureteric bud; physiological concentrations of H G F are also known to require GAGs [25] . Addition of supraphysiological concentrations of HGF to chlorate-treated kidneys stimulates elongation of the ureteric bud but does not stimulate branching (Fig. 2c) , providing early evidence that the two processes are under separate developmental control [ 161. A role for H G F in kidney development is further suggested by antibody-inhibition experiments in culture [28] , but h g f -/ -mice have normal kidneys [29] , so H G F cannot be necessary in wiwo. G D N F is expressed by mesenchyme, and its c-Ret receptor tyrosine kinase is expressed by the ureteric bud, as is its glycosyl-phosphatidylinositol-linked G F R a l co-receptor. Addition of supraphysiological G D N F to chlorate-treated kidneys results in stimulation of branching (Fig.  2d) [30] . In the case of G D N F , transgenic deletion of either the gdnf or the c-ret genes results in the failure of kidney development [31, 32] , which strongly supports the view that G D N F is an important morphogen in wiwo; furthermore, G D N F beads, when placed next to the Wolffian duct, can elicit the formation of supernumerary ureteric buds [30] . Persephin, which also signals via c-Ret (in conjunction with a different GPIlinked co-receptor, GFRa3), also elicits branching in chlorate-treated kidneys [33] . Neurturin is yet another ligand for c-Ret (with GFRa2); again neurturin rescues ureteric bud branching in chlorate-treated kidneys, but neurturin is produced by the ureteric bud itself rather than by the mesenchyme, suggesting that the molecule participates in an autocrine circuit the purpose of which is not yet understood [34] . No other morphoregulatory growth factors have yet been discovered using this method but attempts to rescue branching pharmacologically have identified protein kinase C as a regulator of branching T h e success of this screening strategy, based on rescue of GAG-depleted tissues, suggests that a major role of GAGs in the developing kidney is indeed presentation of growth factors. This is supported by our recent work on receptor and second-messenger activation; we have, for example, found that chlorate greatly reduces the activation of Erk 1 /2 mitogen-activated protein (MAP) kinase pathway, which is a major signaltransduction pathway downstream of c-Ret, and [161.
we are now exploring the role of GAGs in facilitating the c-Ret-MAP kinase axis in other cells and organs.
Future prospects
We now know that GAGs are important to kidney development, and that one of their functions is to facilitate cell-cell signalling. T h e next stages of research (already underway) are to identify which types of GAG/proteoglycan are required for which individual signals, and to determine whether any other signals require GAGs. Rescue of chlorate-treated kidneys by exogenous growth factors has never resulted in perfectly normal morphology (branches look ragged and disorganized), which raises the possibility that GAGs are also required for functions other than presentation of growth factors, for example organization of the extracellular matrix ; this possibility will be investigated in due course.
T h e general strategy of using chlorate-treated organ rudiments to screen candidate growth factors for morphoregulatory activity can be applied to other organs (with the in wiwo relevance of the factors identified again being confirmed by expression and inhibition/knockout studies). This approach could yield valuable results in a great variety of developing organs, and a comparative study of different organs that show branching morphogenesis of epithelia (e.g. kidney, lung, salivary gland) may reveal homologous mechanisms that operate in all such organs, whether at the level of signalling or of other functions of GAGs. What is becoming clear, from the work reviewed here, and also from the contents of other reviews in this volume, is that GAGs can no longer be seen as the province of a small and dedicated band of carbohydrate biochemists, but as molecules that are important to cell and developmental biology as a whole. 
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